Editor(s):
(1) Dr. Jehad M. H. Ighbareyeh, Assistant Professor, Al-Quds Open University, Hebron Branch, Abu Ktellah St., Hebron, Hebron, Palestine.
(2) Prof. Daniele De Wrachien, State University of Milan, Italy.
Reviewers:
(1) Navneet Kumar Verma, Buddha Institute of Pharmacy, India.
(2) Moh. Su’i, Widyagama University of Malang, Indonesia.
(3) Krishna Sujeethasai, University of Jaffna, Sri Lanka.
Additional Reviewers:
(1) Akinlolu Bankole Fawehinmi, Nigeria.
(2) Mutaz Sabah Ahmeid, Ibnsina University of Medical and Pharmaceutical Sciences, Iraq.
(3) Zena M. Qaragholi, University of Baghdad, College of Pharmacy, Iraq.
(4) Zeuko’o Menkem Elisabeth, University of Buea, Cameroon.
Additional Reviewers: (Comments received after deadline)
Open Peer Review Policy: Click Here
Specific Comment:
Average Peer review marks at initial stage: 8.8/10
Average Peer review marks at publication stage: 9/10
Peer Review History:
Stage 1 | Original Manuscript | File 1 | NA
Stage 2 | Peer review report_1 (Navneet Kumar Verma, India) | File 1 | NA
Stage 2 | Peer review report_2 (Moh. Su’I, Indonesia) | File 1 | File 2
Stage 2 | Peer review report_3 (Krishna Sujeethasai, Sri Lanka) | File 1 | NA
Stage 2 | Revised_MS_v1_and_Feedback_v1 | File 1 | File 2
Stage 3 | Comment_Editor_1_v1 | File 1 | NA
Stage 3 | Revised_MS_v2_and_Feedback_v2 | File 1 | NA
Stage 3 | Comment_Editor_2_v1 | File 1 | NA